Next Article in Journal
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers
Previous Article in Journal
Evolution and New Perspectives of Balloon Pulmonary Angioplasty in CTEPH
 
 
Article

Article Versions Notes

J. Clin. Med. 2025, 14(3), 701; https://doi.org/10.3390/jcm14030701
Action Date Notes Link
article xml file uploaded 22 January 2025 11:16 CET Original file -
article xml uploaded. 22 January 2025 11:16 CET Update -
article pdf uploaded. 22 January 2025 11:16 CET Version of Record https://www.mdpi.com/2077-0383/14/3/701/pdf-vor
article supplementary file uploaded. 22 January 2025 11:16 CET - https://www.mdpi.com/2077-0383/14/3/701#supplementary
article html file updated 22 January 2025 11:17 CET Original file -
article xml file uploaded 24 January 2025 10:07 CET Update -
article xml uploaded. 24 January 2025 10:07 CET Update https://www.mdpi.com/2077-0383/14/3/701/xml
article pdf uploaded. 24 January 2025 10:07 CET Updated version of record https://www.mdpi.com/2077-0383/14/3/701/pdf
article html file updated 24 January 2025 10:09 CET Update -
article html file updated 24 June 2025 13:32 CEST Update https://www.mdpi.com/2077-0383/14/3/701/html
Back to TopTop